Prior to approval, CVM evaluates data on proposed new animal or veterinary products.

• A. True
• B. False
• C. Not specified
• D. Only for human products

Answer: (A)

CVM reviews the sponsor’s data before any new veterinary product can be approved. This evaluation covers safety for the animal species, potential risks to humans who may consume products from treated animals (through residue and food-safety considerations), and the product’s efficacy in its target use. It also includes assessments of manufacturing quality and labeling to ensure the product is safe and properly used. This is a core part of CVM’s role in protecting animal health and the safety of the food supply. The focus on animal health means human products aren’t the primary concern of CVM; those go to other FDA centers. So the statement is true.